新華聯資本(00758.HK):法院要求湖南泰基雙方股東於十月中前提交進一步補充資料
格隆匯9月27日丨新華聯資本(00758.HK)公佈,於2019年2月22日,莊勝(建材)有限公司獲湖南泰基通知接獲中國湖南省婁底市中級法院發出的應訴通知書,據此,漣源鋼鐵(作為原告)要求法院判決,由於股東之長期糾紛,於湖南泰基合營協議終止前解散湖南泰基,並已排期於2019年9月25日開庭進行聆訊。
聆訊於2019年9月25日在婁底市中級法院進行,湖南泰基及雙方股東出庭交換證據。婁底市中級法院要求湖南泰基雙方股東於十月中前提交進一步補充資料(如需要)以供其考慮。截至公告日期,訴訟結果尚未作出。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.